Francisco Antônio Helfenstein Fonseca
0000-0002-9911-4598
Publication & Citation Trends
Publications
382 total
Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve
Cited by 279
OpenAlex
Updated Cardiovascular Prevention Guideline of the Brazilian Society of Cardiology - 2019 PDF
Cited by 425
OpenAlex
Modulation of the interleukin-6 signalling pathway and incidence rates of atherosclerotic events and all-cause mortality: analyses from the Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS) PDF
Cited by 542
OpenAlex
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial PDF
Cited by 1,283
OpenAlex
Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial PDF
Cited by 856
OpenAlex
Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein
Cited by 3,658
OpenAlex
Research Topics
Lipoproteins and Cardiovascular Health
(88)
Diabetes, Cardiovascular Risks, and Lipoproteins
(42)
Atherosclerosis and Cardiovascular Diseases
(40)
Acute Myocardial Infarction Research
(27)
Adipokines, Inflammation, and Metabolic Diseases
(27)
Affiliations
University of Copenhagen
Brigham and Women's Hospital
St. Luke's Episcopal Hospital
Harvard University
Universidade Federal de Viçosa